Illumina Announces Scale-Up of Genome Analyzers at The Broad Institute

Illumina, Inc. (NASDAQ:ILMN) today announced that the Broad Institute has purchased 30 additional Genome Analyzers, increasing its total installed base of Illumina systems to 89.

Source: Illumina